Singh; Ravindra N.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Singh; Ravindra N..The latest application filed is for "spinal muscular atrophy (sma) treatment via targeting of smn2 splice site inhibitory sequences".

Company Profile

2.8.10

Singh; Ravindra N. - Shrewsbury MA
Singh; Ravindra N. - Ames IA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Spinal Muscular Atrophy (sma) Treatment Via Targeting Of Smn2 Splice Site Inhibitory Sequences App 20220090071 - Singh; Ravindra N. ; et al.	2022-03-24
Spinal Muscular Atrophy (sma) Treatment Via Targeting Of Smn2 Splice Site Inhibitory Sequences App 20190292540 - Singh; Ravindra N. ; et al.	2019-09-26
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences Grant 10,266,822 - Singh , et al.	2019-04-23
Deep intronic target for splicing correction on spinal muscular atrophy gene Grant 9,856,474 - Singh , et al. January 2, 2	2018-01-02
Spinal Muscular Atrophy (sma) Treatment Via Targeting Of Smn2 Splice Site Inhibitory Sequences App 20170096664 - Singh; Ravindra N. ; et al.	2017-04-06
Spinal Muscular Atrophy Treatment Via Targeting Smn2 Catalytic Core App 20170037397 - Singh; Ravindra N. ; et al.	2017-02-09
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences Grant 9,476,042 - Singh , et al. October 25, 2	2016-10-25
Spinal muscular atrophy treatment via targeting SMN2 catalytic core Grant 9,217,147 - Singh , et al. December 22, 2	2015-12-22
Deep Intronic Target For Splicing Correction On Spinal Muscular Atrophy Gene App 20150315582 - Singh; Ravindra N. ; et al.	2015-11-05
Spinal Muscular Atrophy Treatment Via Targeting Smn2 Catalytic Core App 20140155463 - Singh; Ravindra N. ; et al.	2014-06-05
Spinal Muscular Atrophy (sma) Treatment Via Targeting Of Smn2 Splice Site Inhibitory Sequences App 20140066492 - SINGH; Ravindra N. ; et al.	2014-03-06
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences Grant 8,586,559 - Singh , et al. November 19, 2	2013-11-19
Spinal Muscular Atrophy (sma) Treatment Via Targeting Of Smn2 Splice Site Inhibitory Sequences App 20120165394 - SINGH; Ravindra N. ; et al.	2012-06-28
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences Grant 8,110,560 - Singh , et al. February 7, 2	2012-02-07
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences Grant 7,838,657 - Singh , et al. November 23, 2	2010-11-23
Spinal Muscular Atrophy (sma) Treatment Via Targeting Of Smn2 Splice Site Inhibitory Sequences App 20100087511 - Singh; Ravindra N. ; et al.	2010-04-08
Spinal Muscular Atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences App 20070292408 - Singh; Ravindra N. ; et al.	2007-12-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.